These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
884 related items for PubMed ID: 26986508
21. Chemotherapy-driven dysbiosis in the intestinal microbiome. Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Bruley des Varannes S, Massart S, Moreau P, Potel G, de La Cochetière MF, Batard E, Knights D. Aliment Pharmacol Ther; 2015 Sep; 42(5):515-28. PubMed ID: 26147207 [Abstract] [Full Text] [Related]
22. Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota. Bai X, Deng J, Duan Z, Fu R, Zhu C, Fan D. Phytomedicine; 2024 Jun; 128():155577. PubMed ID: 38608488 [Abstract] [Full Text] [Related]
23. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Aguilera M, Cerdà-Cuéllar M, Martínez V. Gut Microbes; 2015 Jun; 6(1):10-23. PubMed ID: 25531553 [Abstract] [Full Text] [Related]
24. Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2/MyD88/NF-kB pathway and regulation of microbiota. Wu J, Gan Y, Li M, Chen L, Liang J, Zhuo J, Luo H, Xu N, Wu X, Wu Q, Lin Z, Su Z, Liu Y. Biomed Pharmacother; 2020 Apr; 124():109883. PubMed ID: 32004938 [Abstract] [Full Text] [Related]
25. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment. Ekmekciu I, von Klitzing E, Fiebiger U, Neumann C, Bacher P, Scheffold A, Bereswill S, Heimesaat MM. Front Cell Infect Microbiol; 2017 Apr; 7():167. PubMed ID: 28529928 [Abstract] [Full Text] [Related]
26. The role of mucins in mucositis. Thorpe D. Curr Opin Support Palliat Care; 2019 Jun; 13(2):114-118. PubMed ID: 30893104 [Abstract] [Full Text] [Related]
27. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota. Guarino MP, Cicala M, Putignani L, Severi C. World J Gastroenterol; 2016 Dec 07; 22(45):9871-9879. PubMed ID: 28018095 [Abstract] [Full Text] [Related]
28. Interaction between the gut microbiome and mucosal immune system. Shi N, Li N, Duan X, Niu H. Mil Med Res; 2017 Dec 07; 4():14. PubMed ID: 28465831 [Abstract] [Full Text] [Related]
29. Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. Kaczmarek A, Brinkman BM, Heyndrickx L, Vandenabeele P, Krysko DV. J Pathol; 2012 Mar 07; 226(4):598-608. PubMed ID: 21960132 [Abstract] [Full Text] [Related]
30. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. Chen B, Sun L, Zhang X. J Autoimmun; 2017 Sep 07; 83():31-42. PubMed ID: 28342734 [Abstract] [Full Text] [Related]
31. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity. Secombe KR, Coller JK, Gibson RJ, Wardill HR, Bowen JM. Int J Cancer; 2019 May 15; 144(10):2365-2376. PubMed ID: 30155890 [Abstract] [Full Text] [Related]
32. Dioscin Alleviates Cisplatin-Induced Mucositis in Rats by Modulating Gut Microbiota, Enhancing Intestinal Barrier Function and Attenuating TLR4/NF-κB Signaling Cascade. Jin S, Guan T, Wang S, Hu M, Liu X, Huang S, Liu Y. Int J Mol Sci; 2022 Apr 17; 23(8):. PubMed ID: 35457248 [Abstract] [Full Text] [Related]
33. Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. Yiu JH, Dorweiler B, Woo CW. J Mol Med (Berl); 2017 Jan 17; 95(1):13-20. PubMed ID: 27639584 [Abstract] [Full Text] [Related]
34. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D, Nistal E, Martínez-Flórez S, Pisonero-Vaquero S, Olcoz JL, Jover R, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Free Radic Biol Med; 2017 Jan 17; 102():188-202. PubMed ID: 27890642 [Abstract] [Full Text] [Related]
35. Crosstalk Between The Immune Receptors and Gut Microbiota. Mu C, Yang Y, Zhu W. Curr Protein Pept Sci; 2015 Jan 17; 16(7):622-31. PubMed ID: 26122782 [Abstract] [Full Text] [Related]
36. Animal models of chemotherapy-induced mucositis: translational relevance and challenges. Sangild PT, Shen RL, Pontoppidan P, Rathe M. Am J Physiol Gastrointest Liver Physiol; 2018 Feb 01; 314(2):G231-G246. PubMed ID: 29074485 [Abstract] [Full Text] [Related]
37. Rifaximin prevents ethanol-induced liver injury in obese KK-Ay mice through modulation of small intestinal microbiota signature. Kitagawa R, Kon K, Uchiyama A, Arai K, Yamashina S, Kuwahara-Arai K, Kirikae T, Ueno T, Ikejima K. Am J Physiol Gastrointest Liver Physiol; 2019 Nov 01; 317(5):G707-G715. PubMed ID: 31509430 [Abstract] [Full Text] [Related]
38. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis. Rogier R, Ederveen THA, Boekhorst J, Wopereis H, Scher JU, Manasson J, Frambach SJCM, Knol J, Garssen J, van der Kraan PM, Koenders MI, van den Berg WB, van Hijum SAFT, Abdollahi-Roodsaz S. Microbiome; 2017 Jun 23; 5(1):63. PubMed ID: 28645307 [Abstract] [Full Text] [Related]
39. Enteroendocrine cells express functional Toll-like receptors. Bogunovic M, Davé SH, Tilstra JS, Chang DT, Harpaz N, Xiong H, Mayer LF, Plevy SE. Am J Physiol Gastrointest Liver Physiol; 2007 Jun 23; 292(6):G1770-83. PubMed ID: 17395901 [Abstract] [Full Text] [Related]
40. Lactoferrin modulates gut microbiota and Toll-like receptors (TLRs) in mice with dysbiosis induced by antibiotics. Bellés A, Aguirre-Ramírez D, Abad I, Parras-Moltó M, Sánchez L, Grasa L. Food Funct; 2022 May 23; 13(10):5854-5869. PubMed ID: 35545893 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]